Bariatric surgery and the perioperative management of type 2 diabetes: Practical guidelines - 02/02/20
Gestion périopératoire du diabète de type 2 lors de la chirurgie bariatrique: recommandations pratiques
DIAMS study group1
páginas | 9 |
Iconografías | 1 |
Vídeos | 0 |
Otros | 0 |
Resumen |
Keypoints |
• | Management of type 2 diabetes before and after bariatric surgery requires the following: |
• | Recent ophthalmoscopy and cardiac ultrasound before surgery |
• | Monitoring of glucose capillary levels in the immediate postoperative period |
• | Adjustment of insulin treatment made by diabetologist |
• | Use of metformin and DPP-4 inhibitors if a non-insulin glucose lowering treatment is required |
• | HbA1c tested every 6 months even in case of diabetes remission |
Summary |
Background |
Metabolic surgery is now considered as a therapeutic option in type 2 diabetes (T2D). However, few data are available regarding perioperative management of T2D.
Objectives |
To assess current practice among bariatric teams regarding perioperative management of T2D in order to propose guidelines.
Methods |
A two-round Delphi method using online surveys was employed among bariatric teams experts (surgeons, diabetologists, anesthetists, nutritionists): first round, 63 questions covering 6 topics (characteristics of experts/teams, characteristics of patients, operative technique, pre/postoperative management, diabetes remission); second round, 44 items needing clarification. They were discussed within national congress of corresponding learned societies. Consensus was defined as ≥66% agreement.
Results |
A total of 170 experts participated. Experts favored gastric bypass to achieve remission (76.7%). Screening for retinopathy, cardiac ultrasound, and reaching an HbA1c<8% are required in the pre-operative period for 67%, 75.3% and 56.7% of experts, respectively. After surgery, insulin pump should not be stopped, basal insulin should be halved, and bolus insulin should be stopped except if severe hyperglycemia. DPP-IV inhibitors and metformin are preferred after surgery. Patients should be seen by a diabetologist within one month if on oral antidiabetic agents (71.8% of experts), 2 weeks if on injectable treatments (77.1% of experts), and immediately after surgery if on insulin pump (93.5% of experts). Long-term monitoring of HbA1c is necessary even if diabetes remission (100%).
Conclusion |
Rapid postoperative modifications of blood glucose require a close monitoring and a prompt adjustment of diabetes medications.
El texto completo de este artículo está disponible en PDF.Keywords : Metabolic surgery, Diabetes, Guidelines, Bariatric surgery
Esquema
Vol 157 - N° 1
P. 13-21 - février 2020 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?